COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review.

Mahdi BarzegarOmid MirmosayyebMahsa GajarzadehAlireza Afshari-SafaviNasim NehzatSaeed VahebVahid ShaygannajadAmir-Hadi Maghzi

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

Our study suggested that MS did not significantly increase the mortality rate from COVID-19. These data should be interpreted with caution as patients with MS are more likely female and younger compared with the general population where age and male sex seem to be risk factors for worse disease outcome.

Keyphrases

coronavirus disease
sars cov
mass spectrometry
multiple sclerosis
ms ms
electronic health record
respiratory syndrome coronavirus
risk factors
machine learning
deep learning